Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-267453
Filing Date
2025-11-06
Accepted
2025-11-05 18:47:23
Documents
65
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q acad-20250930.htm   iXBRL 10-Q 2325319
2 EX-31.1 acad-ex31_1.htm EX-31.1 11985
3 EX-31.2 acad-ex31_2.htm EX-31.2 12141
4 EX-32.1 acad-ex32_1.htm EX-32.1 8784
5 EX-32.2 acad-ex32_2.htm EX-32.2 8830
  Complete submission text file 0001193125-25-267453.txt   9274021

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acad-20250930.xsd EX-101.SCH 975545
68 EXTRACTED XBRL INSTANCE DOCUMENT acad-20250930_htm.xml XML 1944296
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 251455502
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)